NovImmune SA, of Plan-Les-Ouates, Switzerland, added Michael Steinmetz to its board and appointed David Slack head of corporate and business development...Savient Pharmaceuticals Inc., of East Brunswick, N.J., appointed Louis Ferrari president and CEO...Xenetic Biosciences plc, of London, added Subash Kapre and Thomas Ulich to its scientific advisory board

Akshay Vaishnaw executive vice president and chief medical officer...and Thomas Rollins senior vice president of program and portfolio management

A.P. Pharma Inc., of Redwood City, Calif., added Barry Quart and Stephen Davis to it board...Saladax Biomedical Inc., of Bethlehem, Pa., named Kevin Harter president and CEO...Sequenom Inc., of San Diego, named Carolyn Beaver vice president and chief accounting officer

Gilead Sciences Inc., of Foster City, Calif., appointed Paul Boateng and Hannah Kettler to its health policy advisory board...Macrocure, of Petach Tikva, Israel, named Nissim Mashiach president and CEO...ViaCyte Inc., of San Diego, appointed Paul Laikind president and CEO

Tris Pharma Inc., of Monmouth Junction, N.J., named Amanda Wohlleber vice president of scale-up and technical services and Rajul Parikh vice president, operations...Vaximm AG, of Basel, Switzerland, and Mannheim, Germany, appointed Jean Paul Prieels to its board...Ziopharm Oncology Inc., of New York, appointed Jason Amello executive vice president and chief financial officer

Galena Biopharma Inc., of Lake Oswego, Ore., named Rosemary Mazanet executive vice president and chief medical officer and appointed Robert Figlin to its scientific advisory board...Incline Therapeutics Inc., of Redwood City, Calif, named John Tucker senior vice president and chief commercial officer

AMAG Pharmaceuticals Inc., of Lexington, Mass., appointed William Heiden president and CEO...Blueprint Medicines, of Cambridge, Mass., named George Demetri clinical advisor and member of the scientific advisory board...Cynapsus Therapeutics Inc., of Toronto, nominated Perry Molinoff, Thomas Picone and President and CEO Anthony Giovinazzo to its board

Biodel Inc., of Danbury, Conn., added Julia Brown and Davey Scoon to its board...Knopp Biosciences, of Pittsburgh, named Steven Boyd senior director of chemistry and Ian Reynolds senior director of biology...Sernova Corp., of London, Ontario, elected Bruce Weber and James Parsons to its board

XOMA Corp., of Berkeley, Calif., named Paul Rubin senior vice president, research and development

China Biologic Products Inc., of Beijing, added Zhijun Tong and Sandy (Han) Zhang to its board...Kolltan Pharmaceuticals Inc., of New Haven Conn., named Gerald McMahon president and CEO...Sorbent Therapeutics, of Sunnyvale, Calif., appointed Howard Dittrich chief medical officer and Randall Woods board chairman

and Santosh Varghese vice president of medical affairs...The company promoted Barbara Troupin to vice president, scientific communication and risk management...named CFO Timothy Morris senior vice president, global corporate development and finance

LLC, of Kalamozoo, Mich., added Barbara Cannon to its science and medical advisory board...Northwest Biotherapeutics, of Bethesda, Md., added Navid Malik and Jerry Jasinowski to its board...Syndax Pharmaceuticals Inc., of Waltham, Mass., appointed Arlene Morris CEO and Joanna Horobin president

AcelRx Pharmaceuticals Inc., of Redwood City, Calif., named Kim Gaumer vice president, regulatory affairs and quality assurance...Array BioPharma Inc., of Boulder, Colo., appointed Howard Holden vice president of regulatory affairs and quality assurance...Avion Pharmaceuticals LLC, of Atlanta, appointed Michael Sullivan vice president, sales and marketing

Adventrx Pharmaceuticals Inc., of San Diego, formed a regulatory advisory board (RAB) and appointed Cindy Dinella and Bonnie Hepburn to the RAB, with Frank Sasinowski as RAB advisor...InDex Pharmaceuticals AB, of Stockholm, Sweden, appointed Pernilla Sandwall head of clinical operations and Thomas Knittel chief medical officer

Pluristem Therapeutics Inc., of Haifa, Israel, appointed Jeffrey Olin, Manesh Patel, Petra Reinke and J. Andre Schmidt-lucke to its new peripheral artery disease steering committee...PTC Therapeutics Inc., of South Plainfield, N.J., named Claudia Hirawat president and Mark Boulding executive vice president and chief legal officer

Avanir Pharmaceutics Inc., of Aliso Viejo, Calif., appointed Rohan Palekar senior vice president and chief commercial officer...ImmunoCellular Therapeutics Ltd., of Woodland Hills, Calif., appointed Richard Chin chairman of the compensation committee and added him to its board and the audit committee...Novavax Inc., of Rockville, Md., named John Hermann vice president and general counsel

CombiMatrix Corp., of Irvine, Calif., appointed Richard Ding and Joseph Limber to its board...and Christine Mikail, executive vice president, corporate development, general counsel and secretary

Sirona also appointed Sean Cunliffe chief business officer and board member...Trovagene Inc., of San Diego, named Charlie Rodi vice president and chief technology officer...ValiRx plc, of London, named Hilary Calvert, Richard Harbottle and Jean-Frederic Sauniere to its scientific advisory board

ImmunoGen Inc., of Waltham, Mass., added Kristine Peterson and Dean Mitchell to its board...and added Eunan Maguire senior vice president of strategy and corporate development